A Systemic Screening for TB Disease in High-risk Groups in Barcelona
Launched by FUNDACIÓ INSTITUT GERMANS TRIAS I PUJOL · Nov 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "A Systemic Screening for TB Disease in High-risk Groups in Barcelona," is focused on finding and testing people who are at high risk for active pulmonary tuberculosis (TB) in Barcelona. The goal is to identify individuals who may have this serious lung infection so they can get the care they need. The study is currently looking for participants of all ages and genders who belong to a population that is considered vulnerable to TB.
If you or someone you know is part of a high-risk group for tuberculosis, you may be eligible to participate in this study. The main requirement is that you must belong to a population that has a higher chance of getting TB. As a participant, you can expect to undergo screening tests to check for active TB. Being part of this trial is important because it helps identify and treat TB early, which can prevent it from spreading to others. If you have any questions or want more information about getting involved, please reach out to the study team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Belonging to a population at high risk for tuberculosis (TB)
- Exclusion Criteria:
- • -Not belonging to a population at high risk for tuberculosis (TB)
About Fundació Institut Germans Trias I Pujol
Fundació Institut Germans Trias i Pujol is a leading biomedical research institution based in Spain, dedicated to advancing health sciences through innovative clinical trials and translational research. With a strong commitment to improving patient outcomes, the foundation collaborates with academic, clinical, and industry partners to facilitate cutting-edge studies in various medical fields. Their multidisciplinary approach leverages state-of-the-art facilities and expertise to foster discoveries that translate into practical applications for healthcare, ultimately enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Badalona, , Spain
Patients applied
Trial Officials
Cristina Vilaplana, MD, PhD
Study Chair
Fundació i Hospital Germans Trias i Pujol (IGTP-HUGTIP)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported